Product

Cybellum Announces Availability of Automated VEX Generation to Complement its Automated SBOM Creation Capability

Retrieved on: 
Wednesday, November 9, 2022
Vulnerability management, Sense, Attention, Compliance, TEL, Hotel manager, Product, VEX, Time, Risk management

TEL AVIV, Israel, Nov. 9, 2022 /PRNewswire/ --  Cybellum, provider of the Product Security Platform for connected device manufacturers, announced today the availability of its automated Vulnerability Exploitability Exchange (VEX) generation capability, enhancing product security and facilitating vulnerability information sharing across the supply chain. In conjunction with Cybellum's automated SBOM creation, manufacturers and asset owners can now automatically discover vulnerabilities within their devices and preemptively determine the risk level and exploitability of these vulnerabilities. This will significantly reduce the number of vulnerabilities that require immediate attention, enabling resources to be allocated only to the high risk threats.

Key Points: 
  • In conjunction with Cybellum's automated SBOM creation, manufacturers and asset owners can now automatically discover vulnerabilities within their devices and preemptively determine the risk level and exploitability of these vulnerabilities.
  • Cybellum will be hosting a webinar on this topic, entitled Making Sense of SBOMs and VEX on November 22, 2022 at 2PM EST.
  • "This is where Cybellum's Product Security Platform comes into play with automated SBOM creation, contextual vulnerability analysis, triaging, and VEX generation.
  • With the VEX generation capability, product security teams can significantly reduce the time it takes to build VEX reports, improving supply chain collaboration and speeding up response times to cyber threats."

Celebrating its 20th Anniversary, Business of Design Week 2022 Summit Presents 'Design for Change', Driving Innovation Amid Uncertainty

Retrieved on: 
Wednesday, November 9, 2022
Metaverse, Hong Kong Design Institute, Marketing, HKSAR, Social, Partnership, City, BODW, Hong Kong Trade Development Council, Hong Kong Polytechnic University, InvestHK, HK Television Entertainment, University School, Mainland, Design Week, Macdonald, PMQ, Business, HKDI, Commerce, Policy, Government, Summit, Product design, Business of Design Week, Culture, Leadership, Product, Social media, M, CEO, Film, Hatmaking, Tutoring

HONG KONG, Nov. 9, 2022 /PRNewswire/ -- On the occasion of its 20th anniversary, Business of Design Week (BODW) 2022, Asia's premier annual event on design, innovation and brands, will make a grand return from 28 November until 3 December. Since 2002, BODW has gathered the most sought-after creative leaders in the world, with a host of concurrent design-related initiatives that have made BODW one of Hong Kong's most anticipated events. BODW has also strengthened collaborations across borders, joining forces with 13 partner countries and cities in the last 20 years.

Key Points: 
  • Headlining BODW 2022 are Chi Wing Lo, Richard Hutten, Ross Lovegrove, Nikki Gonnissen, Rossana Hu, Bill Bensley, Sylvain Roca; more to be announced.
  • Speakers to fly in from the Netherlands, UK, France, Thailand and around the world for the first time since 2018.
  • HONG KONG, Nov. 9, 2022 /PRNewswire/ -- On the occasion of its 20thanniversary, Business of Design Week (BODW) 2022, Asia's premier annual event on design, innovation and brands, will make a grand return from 28 November until 3 December.
  • This year's BODW Summit will welcome international speakers from UK, France, Thailand, Japan, Korea, as well as from the Netherlands, BODW's Strategic Partner for 2022.

Celebrating its 20th Anniversary, Business of Design Week 2022 Summit Presents 'Design for Change', Driving Innovation Amid Uncertainty

Retrieved on: 
Wednesday, November 9, 2022
Metaverse, Hong Kong Design Institute, Marketing, HKSAR, Social, Partnership, City, BODW, Hong Kong Trade Development Council, Hong Kong Polytechnic University, InvestHK, HK Television Entertainment, University School, Mainland, Design Week, Macdonald, PMQ, Business, HKDI, Commerce, Policy, Government, Summit, Product design, Business of Design Week, Culture, Leadership, Product, Social media, M, CEO, Film, Hatmaking, Tutoring

HONG KONG, Nov. 9, 2022 /PRNewswire/ -- On the occasion of its 20th anniversary, Business of Design Week (BODW) 2022, Asia's premier annual event on design, innovation and brands, will make a grand return from 28 November until 3 December. Since 2002, BODW has gathered the most sought-after creative leaders in the world, with a host of concurrent design-related initiatives that have made BODW one of Hong Kong's most anticipated events. BODW has also strengthened collaborations across borders, joining forces with 13 partner countries and cities in the last 20 years.

Key Points: 
  • Headlining BODW 2022 are Chi Wing Lo, Richard Hutten, Ross Lovegrove, Nikki Gonnissen, Rossana Hu, Bill Bensley, Sylvain Roca; more to be announced.
  • Speakers to fly in from the Netherlands, UK, France, Thailand and around the world for the first time since 2018.
  • HONG KONG, Nov. 9, 2022 /PRNewswire/ -- On the occasion of its 20thanniversary, Business of Design Week (BODW) 2022, Asia's premier annual event on design, innovation and brands, will make a grand return from 28 November until 3 December.
  • This year's BODW Summit will welcome international speakers from UK, France, Thailand, Japan, Korea, as well as from the Netherlands, BODW's Strategic Partner for 2022.

Market Synergy Group, Aspida to Partner in Distribution of New Fixed Index Annuity Series

Retrieved on: 
Tuesday, November 8, 2022
OR, Growth, Citigroup, SALT, S&P Global, Person, COST, IP, Solution, S&P, Synergy, Element, LOST, Agility, FIA, Dream, Retirement, IMO, Partnership, Goldman Sachs, Product, Standard, ARE, Financial services, AND, SPECIAL, Bermuda, MAX, Technology, INDEX, Dow Jones, ALL, Insurance, ANY, Research, S&P Global Ratings, S&P Global 100, Life insurance, Fine chemical, Financial adviser, Security (finance), ASPIDA, Index, Licensee

TOPEKA, Kan., Nov. 8, 2022 /PRNewswire-PRWeb/ -- Aspida Life Insurance Company ("Aspida"), a life insurance and annuity company, and Market Synergy Group announced plans on Monday to partner on the distribution of Aspida's new Synergy Choice™ Max fixed index annuity (FIA) series.

Key Points: 
  • TOPEKA, Kan., Nov. 8, 2022 /PRNewswire-PRWeb/ -- Aspida Life Insurance Company ("Aspida"), a life insurance and annuity company, and Market Synergy Group announced plans on Monday to partner on the distribution of Aspida's new Synergy Choice Max fixed index annuity (FIA) series.
  • Aspida's Synergy Choice Max FIA, designed in partnership with Market Synergy Group, adds to the already popular suite of Synergy Choice products, which includes a multi-year guaranteed annuity series that launched earlier this year.
  • "The strategy designs available with Synergy Choice Max will help Aspida stand out in the FIA marketplace.
  • "Given the current markets, we believe it's a great time to introduce the Synergy Choice Max FIA through our partnership with Market Synergy Group," said Aspida Chief Distribution Officer Chad Burns.

Global Industrial Gases Market to Reach $130.3 Billion by 2027

Retrieved on: 
Tuesday, November 8, 2022
Hydrogen, Carbon, Argon, Growth, Application, CAGR, Health care, Acetylene, Metallurgy, Producer gas, COVID-19, Glass, Nitrogen, International Federation of Chemical, Energy, Mine and General Workers' Unions, Merchant, Pet, Renewable energy, Cereal, Flowers, Petroleum, Coal, Powder metallurgy, Industrial gas, Fertilizer, Animal, Oxygen, Product

View original content:https://www.prnewswire.com/news-releases/global-industrial-gases-market-...

Key Points: 
  • In the changed post COVID-19 business landscape, the global market for Industrial Gases estimated at US$90.2 Billion in the year 2020, is projected to reach a revised size of US$130.3 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027.
  • The U.S. Market is Estimated at $24.8 Billion, While China is Forecast to Grow at 9.1% CAGR
    The Industrial Gases market in the U.S. is estimated at US$24.8 Billion in the year 2020.
  • China, the world`s second largest economy, is forecast to reach a projected market size of US$26.8 Billion by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$17.3 Billion by the year 2027.

Global Industrial Tapes Market to Reach $13.6 Billion by 2027

Retrieved on: 
Tuesday, November 8, 2022
Transfer, Paper, Industry, Growth, CAGR, End Use Energy Demand Centres, COVID-19, Polyvinyl chloride, Pet, Renewable energy, Flowers, Cereal, Chemical, Cassette tape, Printed circuit board, Animal, Office supplies, Heating, ventilation, and air conditioning, Commodity plastics, Aluminium, Material, Product

View original content:https://www.prnewswire.com/news-releases/global-industrial-tapes-market-...

Key Points: 
  • In the changed post COVID-19 business landscape, the global market for Industrial Tapes estimated at US$9.8 Billion in the year 2020, is projected to reach a revised size of US$13.6 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027.
  • The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 8.3% CAGR
    The Industrial Tapes market in the U.S. is estimated at US$2.7 Billion in the year 2020.
  • China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.8 Billion by the year 2027.

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

Retrieved on: 
Monday, November 7, 2022
Pigment, Plasma, VUS, Growth, Private Securities Litigation Reform Act, Excipient, Proopiomelanocortin, Benzyl alcohol, Blood pressure, PCSK1, Bardet–Biedl syndrome, Nasdaq, Professional Football Compensation Committee, Toxicity, Population, Weight loss, Risk, Time, Financial compensation, Pregnancy, Skin, Obesity, Depression, United, COVID-19, Alström syndrome, BBS, Product, DNA, Genetic testing, Milk, Hunger, GLOBE, Priapism, RSU, FDA, Patient, Medicines and Healthcare products Regulatory Agency, Data analysis, Heart rate, Fertility, Child, Safety, Adult, MC4R, Food, Diagnosis, Cyprus Securities and Exchange Commission, Metabolic acidosis, LEPR, EC, Allergy, Employment, MHRA, Polyphagia, Pharmaceutical industry, Dietary supplement, Medicine, Birth control, Setmelanotide, European, POMC

About Rhythm PharmaceuticalsRhythm is a commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases. Rhythm’s precision medicine, setmelanotide, is approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adult and pediatric patients 6 years of age and older with monogenic or syndromic obesity due to pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1) or leptin receptor (LEPR) deficiency confirmed by genetic testing, or patients with a clinical diagnosis of Bardet-Biedl syndrome (BBS). The European Commission (EC) has authorized setmelanotide for the treatment of obesity and the control of hunger associated with genetically confirmed BBS or genetically confirmed loss-of-function biallelic POMC, including PCSK1, deficiency or biallelic LEPR deficiency in adults and children 6 years of age and above.The UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) authorized setmelanotide for the treatment of obesity and the control of hunger associated with genetically confirmed loss-of-function biallelic POMC, including PCSK1, deficiency or biallelic LEPR deficiency in adults and children 6 years of age and above. Additionally, Rhythm is advancing a broad clinical development program for setmelanotide in other rare genetic diseases of obesity and is leveraging the Rhythm Engine and the largest known obesity DNA database -- now with approximately 45,000 sequencing samples -- to improve the understanding, diagnosis and care of people living with severe obesity due to certain genetic deficiencies. Rhythm’s headquarters is in Boston, MA.

Key Points: 
  • These inducement stock options and inducement RSUs are subject to the terms of the Rhythm Pharmaceuticals, Inc. 2022 Employment Inducement Plan (the "Inducement Plan").
  • The Inducement Plan is used exclusively for the grant of equity awards to individuals as an inducement material to the employees entering into employment with Rhythm pursuant to Nasdaq Listing Rule 5635(c)(4).
  • The Inducement Plan was adopted by Rhythms board of directors on February 9, 2022.
  • Rhythm is a commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases.

Global Microarray Market Report 2022: Rise in the Usage of Microarrays in Various Applications Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, November 7, 2022
Other Health, Software, Research, Radiology, Pharmaceutical, Hardware, Technology, Genetics, Science, Biotechnology, Other Science, Health, Observation, Industry, Viral Research and Diagnostic Laboratories, Ansoff Matrix, Growth, Personal Software Services, CAGR, Academic institution, Market development, Geography, Software, Antibody microarray, USD, SWOT, Microarray, Drug discovery, Product, Medication, COVID-19, Biotechnology, Product-service system, Porter's five forces analysis, Risk, Medical device, Risk management, Pharmaceutical industry, Chemical substance, Application

By Type, the market is classified into Antibody Microarrays, Cellular Microarrays, Chemical compound Microarrays, DNA Microarrays, Peptide Microarrays, and Others.

Key Points: 
  • By Type, the market is classified into Antibody Microarrays, Cellular Microarrays, Chemical compound Microarrays, DNA Microarrays, Peptide Microarrays, and Others.
  • The report presents a detailed Ansoff matrix analysis for the Global Microarray Market.
  • The analyst analyses the Global Microarray Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global Microarray Market.

Snowflake Unveils New Performance Innovations and Enhanced Cross-Cloud Capabilities for Industry-Leading Data Platform

Retrieved on: 
Monday, November 7, 2022
Software, Networks, Data Analytics, Internet, Data Management, Professional Services, Technology, Security, Cloud, Organization, Senior, U.S. Securities and Exchange Commission, UI, Growth, Compliance, Metadata, Forbes, NYSE, Analysis, Report, Privacy, Snowflake Inc., SNOW, DoorDash, Economics, 2005 Forbes Global CEO Conference, Policy, Table, Tag cloud, Private, Multimedia, Security (finance), Technology, Video game console, Online shopping, Computer data storage, Risk management, Autodesk, Snowflake, Product

View the full release here: https://www.businesswire.com/news/home/20221107005226/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221107005226/en/
    Snowflake Unveils New Performance Innovations and Enhanced Cross-Cloud Capabilities for Industry-Leading Data Platform (Graphic: Business Wire)
    Snowflake is and always has been a customer-first organization , and is committed to continuous innovations that improve performance, reduce latencies, and advance economics for customers.
  • Snowflakes latest improvements continue this trend of performance enhancements, and provide new visibility into the impact of performance optimizations.
  • Customers use the Data Cloud to unite siloed data, discover and securely share data, and execute diverse analytic workloads.
  • Wherever data or users live, Snowflake delivers a single data experience that spans multiple clouds and geographies.

Neat Levels the Playing Field for Hybrid Teams by Bringing Everyone in the Meeting Room Front and Center

Retrieved on: 
Monday, November 7, 2022
Consumer Electronics, Technology, Audio, Video, Telecommunications, Mobile, Wireless, Networks, Hardware, Zoom, Microsoft Teams, Product, Microsoft, Camera, Liquor, Neat

It brings remote participants to the front and center of the meeting room conversation for complete meeting equity.

Key Points: 
  • It brings remote participants to the front and center of the meeting room conversation for complete meeting equity.
  • As hybrid work continues to evolve, an ever-increasing amount of people are returning to the office to collaborate and see their colleagues.
  • Neat Center extends the experience of Neat Symmetry to make sure everyone in the room can be equally seen and heard, elevating the feeling of inclusion for all."
  • Neat Center is designed to seamlessly work with Zoom and Microsoft Teams to deliver an outstanding hybrid meeting experience every time.